查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1931299

橈骨頭切除植入市場按產品類型、材料、最終用戶和分銷管道分類，全球預測（2026-2032年）

Radial Head Resection Implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，橈骨頭切除植入市場價值將達到 6,525 萬美元，到 2026 年將成長至 7,172 萬美元，到 2032 年將達到 1.079 億美元，年複合成長率為 7.44%。

關鍵市場統計數據
基準年 2025 6525萬美元
預計年份：2026年 7172萬美元
預測年份 2032 1.079億美元
複合年成長率 (%) 7.44%

本文重點介紹影響橈骨頭切除植入開發和應用的臨床需求、手術趨勢和商業性因素。

橈骨頭切除植入領域處於整形外科創新和複雜臨床決策的交匯點，需要對器械設計、手術方法和相關人員的期望有深入的了解。本報告首先簡要概述了需要橈骨頭置換解決方案的臨床背景，重點介紹了影響器械選擇和手術技術應用的適應症、患者特徵和術後目標。

分析臨床實務、器材工程和醫療服務體系的變革，這些變革正在重塑橈骨頭植入領域的競爭動態。

近年來，整個橈骨頭植入生態系統經歷了變革性的變化，重新定義了競爭優勢，不再局限於漸進式的產品更新，而是從設備的設計、交付和支持方式等方面進行了系統性變革。生物材料科學的進步，包括表面處理和合金選擇，提高了骨整合性和耐磨性，進而影響外科醫師的選擇和長期臨床療效。

美國關稅政策展望至2025年：全面剖析近期發展如何重塑植入生態系的供應鏈、籌資策略與購買行為。

美國2025年前的關稅調整前景，正在為橈骨頭切除植入的製造商和經銷商創造新的商業環境，促使相關人員重新評估其供應鏈佈局和籌資策略。這些貿易措施的累積影響在採購行為中顯而易見：買家對到岸成本和前置作業時間的波動更加敏感，採購規範也更加強調供應商多元化和盡可能使用國產產品。

詳細的細分分析揭示了產品類型、材料選擇、最終用戶特徵和分銷管道如何共同決定產品定位和商業化優先順序。

市場區隔洞察揭示了產品設計選擇和分銷策略與臨床需求和客戶期望的交匯點，突顯了製造商面臨的關鍵差異化挑戰。在評估產品類型時，對於需要即時固定或牢固骨界面的情況，骨水泥型植入仍然具有價值；而對於那些優先考慮生物整合和長期骨保存的臨床醫生而言，非骨水泥型植入則更受歡迎。骨水泥型和非骨水泥型植入物之間的選擇會影響手術器械、手術流程和訓練需求。

從區域觀點分析美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、監管複雜性和商業性要務，以指導市場進入和擴張。

區域趨勢塑造了投資、臨床應用和監管重點的整合領域，從而在美洲、歐洲、中東和非洲以及亞太地區形成了各自獨特的戰略要務。在美洲，高流量專科醫療中心的集中分佈和先進的醫保報銷系統推動了對技術差異化植入和全面臨床支援的需求。該地區的買家往往優先考慮臨床證據、外科醫生培訓計畫和一體化服務模式。

深入了解競爭態勢、夥伴關係模式和能力投資，這些因素將決定哪些公司將在植入市場中獲得臨床應用和採購優勢。

隨著成熟的整形外科公司和專注於特定領域的新興企業尋求不同的臨床應用和商業性化路徑，橈骨頭植入領域的競爭動態正在不斷演變。大規模跨國製造商往往利用其整合的銷售團隊、廣泛的外科培訓項目和多元化的產品系列來贏得醫院合約並支持長期的臨床研究。同時，規模小規模、更專注於特定領域的公司則傾向於在材料、模組化設計或特定手術適應症方面進行敏捷創新，以吸引早期採用的臨床醫生。

為產品、價值鏈和商業領導者提供切實可行的建議，以推動產品應用、確保業務永續營運，並在不斷變化的植入環境中創造差異化價值。

為了抓住臨床和商業性機遇，產業領導者應採取一系列策略行動，兼顧短期韌性和中期差異化。首先，優先發展模組化產品設計，使其能夠同時適用於有骨水泥和非骨水泥兩種技術，這將拓寬臨床應用範圍，降低產品種類複雜性，並提高產品在不同手術環境中的普及率。

一種透明且可重複的調查方法，結合了對臨床醫生的訪談、技術審查、專家檢驗和情境分析，以支持策略洞察。

本報告的研究整合了多方面的資料收集和嚴格的檢驗通訊協定，以確保研究結果具有實證性和可操作性。主要研究包括對骨科醫生、採購負責人和供應鏈經理進行結構化訪談，並輔以來自手術中心和醫院的案例研究，以了解醫療設備的實際使用和採購趨勢。次要研究涵蓋監管文件、臨床文獻、標準文件和公共採購檢驗，以驗證主要研究結果，並為技術評估奠定基礎。

這份簡明扼要的摘要重點闡述了產品品質卓越、臨床協作和供應鏈韌性這三大綜合優先事項，它們將決定該領域的長期成功。

總之，橈骨頭切除植入領域正處於一個轉折點，材料科學、外科技術的進步和商業模式的創新在此交匯融合，重新定義價值創造。能夠將產品設計與臨床工作流程相結合、投資外科醫生培訓並建立穩健供應鏈的製造商，將在各種臨床環境中獲得市場認可方面佔據優勢。對市場區隔進行策略性考量——平衡有骨水泥型和非有骨水泥型植入物、選擇滿足臨床需求的材料以及為門診手術中心和醫院制定客製化的商業性策略——將決定其市場佔有率。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 橈骨頭切除植入市場（依產品類型分類）

  • 水泥固位植入
  • 非骨水泥型植入

9. 橈骨頭切除植入市場（依材料分類）

  • 鈷鉻
  • 不銹鋼
  • 鈦

第10章 橈骨頭切除植入市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 橈骨頭切除植入市場（依分銷管道分類）

  • 線上
  • 離線

第12章 橈骨頭切除植入市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 橈骨頭切除植入市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國橈骨頭切除植入市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國橈骨頭切除植入市場

16. 中國橈骨頭切除植入市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acumed LLC
  • Arthrex Inc
  • Atlas Surgical
  • B. Braun Melsungen AG
  • CONMED Corporation
  • DePuy Synthes
  • Exactech Inc
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Narang Medical Limited
  • Orthofix Medical Inc
  • OsteoMed
  • RTI Surgical Holdings Inc
  • Sharma Orthopedic India Pvt Ltd
  • Siora Surgicals Pvt Ltd
  • Smith & Nephew Plc
  • Stryker Corporation
  • Tornier（now part of Stryker）
  • Wright Medical Group NV
  • XLO India
  • Zimmer Biomet Holdings Inc
Product Code: MRR-7B550E008E17

The Radial Head Resection Implant Market was valued at USD 65.25 million in 2025 and is projected to grow to USD 71.72 million in 2026, with a CAGR of 7.44%, reaching USD 107.90 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 65.25 million
Estimated Year [2026] USD 71.72 million
Forecast Year [2032] USD 107.90 million
CAGR (%) 7.44%

A focused introduction framing the clinical imperatives, surgical trends, and commercial forces shaping development and adoption of radial head resection implants

The radial head resection implant domain sits at the intersection of orthopedic innovation and complex clinical decision-making, requiring an informed view of device design, surgical approaches, and stakeholder expectations. This report opens with a concise orientation to the clinical context that necessitates radial head replacement solutions, emphasizing indications, patient profiles, and postoperative objectives that drive device selection and procedural adoption.

Clinicians increasingly balance functional restoration with implant longevity and soft-tissue preservation, prompting device developers to refine fixation mechanisms, surface engineering, and modularity. Concurrently, healthcare providers are recalibrating procurement and care pathways to optimize patient throughput and cost-effectiveness, which in turn informs product requirements and commercialization strategies. By situating product evolution within the realities of surgical workflows, regulatory oversight, and hospital economics, this introduction sets the stage for deeper analysis on how manufacturers, clinicians, and payers converge around performance, safety, and value in the radial head implant space.

An analysis of systemic shifts across clinical practice, device engineering, and care delivery that are reshaping competitive dynamics in the radial head implant sector

Recent years have seen transformative shifts that are redefining competitive advantage across the radial head implant ecosystem, moving beyond incremental product updates toward systemic changes in how devices are designed, delivered, and supported. Advances in biomaterials science, including surface treatments and alloy selection, are enabling improvements in osseointegration and wear resistance, which in turn influence surgeon preference and long-term clinical outcomes.

Simultaneously, minimally invasive techniques and enhanced imaging capabilities have altered procedural expectations, encouraging manufacturers to prioritize modularity and intraoperative flexibility. These clinical shifts coincide with structural changes in procurement and care delivery: ambulatory surgical centers are capturing a larger share of elective orthopedic procedures, and hospitals are consolidating purchasing to negotiate more favorable contracts. Finally, digital tools for surgical planning, postoperative monitoring, and remote training are creating new channels for product differentiation and customer engagement, driving a more service-oriented commercial model across the implant value chain.

A comprehensive view of how recent United States tariff developments through 2025 are reshaping supply chains, sourcing strategies, and procurement behavior across the implant ecosystem

Anticipated tariff adjustments in the United States through 2025 have created a new operational backdrop for manufacturers and distributors of radial head resection implants, prompting stakeholders to reassess supply chain footprints and sourcing strategies. The cumulative impact of these trade measures is evident in procurement behavior, where buyers are increasingly sensitive to landed costs and lead-time volatility, and in procurement specifications that emphasize supplier diversification and domestic content where feasible.

In response, many suppliers have accelerated nearshoring and capacity-building initiatives to mitigate exposure to import duties. This structural shift often involves higher upfront capital commitments but can yield greater resilience in production continuity and quality control. Meanwhile, distributors and health systems are re-evaluating inventory strategies to balance working capital constraints against potential supply disruptions. Regulatory and reimbursement environments further complicate this picture, as any cost pass-through to providers or patients pressures adoption decisions. Cumulatively, the tariff-related environment is catalyzing strategic realignment across manufacturing, logistics, and commercial negotiations, raising the bar for operational flexibility and cost management without supplanting the core clinical requirements that govern device selection.

Deep segmentation analysis revealing how product type, material choices, end-user characteristics, and distribution channels collectively determine product positioning and commercialization priorities

Segmentation insights illuminate where product design choices and channel strategies intersect with clinical requirements and customer expectations, revealing differentiated imperatives for manufacturers. When assessing product type, cemented implants remain relevant for cases requiring immediate fixation and where bone quality dictates a secure interface, whereas non-cemented implants appeal to clinicians prioritizing biological integration and long-term bone preservation; the choice between cemented and non-cemented approaches informs instrumentation, surgical workflow, and training needs.

Material selection further nuances competitive positioning: cobalt chromium alloys are favored where wear resistance and strength are paramount, stainless steel maintains a role for cost-sensitive constructs, and titanium offers superior biocompatibility and osseointegration potential for cases emphasizing bone affinity. End-user segmentation highlights operational and procurement differences between ambulatory surgical centers and hospitals; free-standing ambulatory surgical centers typically prioritize shorter procedures and streamlined inventories, while hospital-affiliated ASCs may leverage broader clinical networks and negotiated purchasing. Private hospitals often pursue specialized service lines and premium device offerings, while public hospitals emphasize cost containment and standardized product sets. Distribution channel choices also matter: direct sales relationships enhance clinical training and post-market surveillance capabilities for manufacturers, whereas third-party distributors provide scale, geographic reach, and logistical capabilities that facilitate rapid market penetration. Together, these segmentation dimensions create a matrix of strategic trade-offs that manufacturers must navigate to match product attributes, commercial models, and service offerings to distinct clinical environments and procurement behaviors.

A regional perspective on demand drivers, regulatory complexity, and commercial imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that guide market entry and expansion

Regional dynamics shape where investment, clinical adoption, and regulatory emphasis converge, producing distinct strategic imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of high-volume specialist centers and advanced reimbursement systems drives demand for technologically differentiated implants and comprehensive clinical support; buyers in this region often value clinical evidence, surgeon training programs, and integrated service models.

The Europe, Middle East & Africa region presents a diverse landscape where regulatory harmonization in some markets contrasts with procurement constraints in others, necessitating flexible pricing strategies and adaptable commercial approaches. Local manufacturing and distributor partnerships can be critical to winning tenders and establishing long-term relationships with both public and private hospitals. The Asia-Pacific region combines rapid procedural volume growth with variable regulatory clarity, creating opportunities for scalable manufacturing, cost-competitive materials, and partnerships with regional distributors to accelerate adoption. Across all regions, cross-border supply chain considerations, reimbursement landscapes, and clinical practice standards influence the pace of adoption and the criteria by which implants are evaluated, underscoring the importance of regionally tailored strategies for product development and market entry.

Insight into competitive postures, partnership models, and capability investments that determine which companies gain clinical adoption and procurement advantage in the implant marketplace

Competitive dynamics in the radial head implant arena are evolving as established orthopedic firms and specialized challengers pursue different paths to clinical relevance and commercial traction. Larger multinational manufacturers often leverage integrated salesforces, broad surgical training programs, and diversified portfolios to secure hospital contracts and support long-term clinical studies, while smaller, specialized firms tend to focus on nimble innovation in materials, modularity, or niche surgical indications that attract early-adopter clinicians.

Partnerships between device makers and contract manufacturers have become more prominent as companies seek to balance speed-to-market with capital efficiency. Additionally, strategic collaborations with distributor networks or value-added service providers allow manufacturers to extend geographic reach without heavy upfront investment in local infrastructure. Mergers and acquisitions remain a mechanism for rapid capability expansion, particularly to acquire novel surface technologies, instrumentation systems, or regulatory dossiers. Across the competitive landscape, successful players are those that align product differentiation with robust clinical evidence, deliver comprehensive surgeon education, and demonstrate supply chain reliability, particularly in an environment where procurement teams scrutinize total cost of ownership and operational continuity.

Action-oriented, pragmatic recommendations for product, supply chain, and commercial leaders to drive adoption, resilience, and differentiated value in a shifting implant ecosystem

Industry leaders should pursue a portfolio of strategic actions that balance near-term resilience with medium-term differentiation to capture clinical and commercial opportunities. First, prioritizing modular product designs compatible with both cemented and non-cemented techniques expands clinical applicability and reduces SKU complexity, thereby increasing the probability of adoption across diverse surgical settings.

Second, investing in a materials roadmap that leverages titanium for biocompatibility while maintaining options in cobalt chromium or stainless steel for specific mechanical requirements enables targeted value propositions for distinct surgeon preferences. Third, supply chain strategies should emphasize dual sourcing, strategic nearshoring, and inventory optimization to mitigate tariff-driven cost volatility and logistics disruptions. Fourth, cultivating direct clinical relationships through hands-on surgeon training, outcome registries, and post-market surveillance builds trust and accelerates uptake in premium settings, while partnering with third-party distributors can accelerate scale into cost-sensitive or geographically dispersed markets. Fifth, commercial teams should develop segmented pricing and reimbursement strategies aligned to ambulatory surgical centers versus hospital procurement dynamics, and tailor commercial models to free-standing ASCs, hospital-affiliated ASCs, private hospitals, and public institutions. Finally, leaders must incorporate digital enablement-surgical planning tools, remote training, and post-operative monitoring-to differentiate the offering and create recurring value streams beyond the implant itself.

A transparent and reproducible research methodology combining primary clinician interviews, secondary technical review, expert validation, and scenario-based analysis to underpin strategic insights

The research underpinning this report integrates multi-source data collection and rigorous validation protocols to ensure insights are evidence-based and actionable. Primary research included structured interviews with orthopedic surgeons, procurement officers, and supply chain managers, supplemented by case studies of surgical centers and hospitals to capture real-world device use and purchasing dynamics. Secondary research encompassed regulatory filings, clinical literature, standards documentation, and publicly available procurement records to triangulate primary insights and anchor technical assessments.

Analytical methods combined qualitative synthesis with scenario analysis to explore outcomes under different regulatory, tariff, and adoption pathways. Expert panels reviewed preliminary findings to validate assumptions and highlight emerging signals in clinical practice and supplier strategy. Quality assurance procedures included cross-checking interview transcripts, verifying citations, and documenting methodological limitations; where data gaps existed, conservative assumptions were applied and clearly annotated. The methodology aims to provide decision-makers with transparent, reproducible insights, while acknowledging that evolving clinical evidence and policy changes may alter specific dynamics over time.

A concise concluding synthesis highlighting the integrated priorities of product excellence, clinical engagement, and supply chain resilience that determine long-term success in the sector

In summary, the radial head resection implant field is at an inflection point where material science, surgical technique evolution, and commercial model innovation converge to redefine value creation. Manufacturers that align product design with clinical workflows, invest in surgeon education, and build resilient supply chains will be better positioned to capture adoption across differentiated care settings. Strategic attention to segmentation-balancing cemented and non-cemented options, selecting materials that match clinical requirements, and customizing commercial approaches for ambulatory surgical centers and hospitals-will determine market relevance.

Moreover, regional nuances in procurement, regulation, and clinical practice necessitate tailored entry strategies that respect local dynamics while leveraging global capabilities. The cumulative effects of tariff changes and supply chain pressures underscore the need for operational flexibility and closer collaboration between manufacturers, distributors, and healthcare providers. Ultimately, success in this sector will depend on an integrated approach that combines product performance, evidence generation, and robust commercial execution to meet surgeon expectations and deliver reliable patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radial Head Resection Implant Market, by Product Type

  • 8.1. Cemented Implant
  • 8.2. Non-Cemented Implant

9. Radial Head Resection Implant Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Stainless Steel
  • 9.3. Titanium

10. Radial Head Resection Implant Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Radial Head Resection Implant Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Radial Head Resection Implant Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radial Head Resection Implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radial Head Resection Implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radial Head Resection Implant Market

16. China Radial Head Resection Implant Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acumed LLC
  • 17.6. Arthrex Inc
  • 17.7. Atlas Surgical
  • 17.8. B. Braun Melsungen AG
  • 17.9. CONMED Corporation
  • 17.10. DePuy Synthes
  • 17.11. Exactech Inc
  • 17.12. Globus Medical Inc
  • 17.13. Integra LifeSciences Holdings Corporation
  • 17.14. Medtronic Plc
  • 17.15. MicroPort Scientific Corporation
  • 17.16. Narang Medical Limited
  • 17.17. Orthofix Medical Inc
  • 17.18. OsteoMed
  • 17.19. RTI Surgical Holdings Inc
  • 17.20. Sharma Orthopedic India Pvt Ltd
  • 17.21. Siora Surgicals Pvt Ltd
  • 17.22. Smith & Nephew Plc
  • 17.23. Stryker Corporation
  • 17.24. Tornier (now part of Stryker)
  • 17.25. Wright Medical Group N.V.
  • 17.26. XLO India
  • 17.27. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY CEMENTED IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY NON-CEMENTED IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. GCC RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. G7 RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. NATO RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA RADIAL HEAD RESECTION IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)